MON - Monsanto Company

NYSE - NYSE Delayed Price. Currency in USD
124.60
-0.35 (-0.28%)
At close: 4:01PM EDT
Stock chart is not supported by your current browser
Previous Close124.95
Open124.90
Bid124.00 x 100
Ask126.99 x 100
Day's Range124.27 - 125.07
52 Week Range114.19 - 126.80
Volume3,919,135
Avg. Volume3,904,548
Market Cap54.984B
Beta0.92
PE Ratio (TTM)22.32
EPS (TTM)5.58
Earnings DateJun 26, 2018 - Jul 2, 2018
Forward Dividend & Yield2.16 (1.72%)
Ex-Dividend Date2018-04-05
1y Target Est126.40
Trade prices are not sourced from all markets
  • Bayer shares up on report Monsanto deal to get U.S. approval
    Reuters Videos10 days ago

    Bayer shares up on report Monsanto deal to get U.S. approval

    The U.S. Justice Department will allow German drugs and pesticides group Bayer AG to acquire Monsanto Co in a $62.5 billion deal, after the companies agreed to sell more assets to win antitrust approval, the Wall Street Journal has reported, sending shares of Monsanto, the world's biggest seed company, close to a four-year high. Sonia Legg reports

  • The Wall Street Journal9 hours ago

    [$$] Data Collective Brings on Monsanto Execs for DCVC Bio

    Data Collective has set up a new fund focused on biotechnology, according to a regulatory filing. The firm has brought on Kiersten Stead and John Hamer as general partners for the fund called DCVC Bio LP.

  • Bayer to Divest 3.6% Stake to Singapore Company Temasek
    Zacksyesterday

    Bayer to Divest 3.6% Stake to Singapore Company Temasek

    Bayer (BAYRY) will divest its 3.6% stake to Singapore's state investment company Temasek for total gross proceeds of ???3 billion.

  • The Wall Street Journal3 days ago

    [$$] Bayer's Monsanto Takeover Explained

    The U.S. Department of Justice is poised to give Bayer the go-ahead for its multibillion-dollar takeover of Monsanto, nearly two years after the company made its first approach in May 2016. Dow Jones explains....

  • Financial Times3 days ago

    [$$] Bayer/Temasek: root map

    After 18 months of gestation, Bayer , the German life sciences group, may finally bring its September 2016 acquisition of US seed maker Monsanto to fruition. Despite European Commission approval last month, ...

  • Five Agrochemical Stocks Hedge Funds Like
    Insider Monkey4 days ago

    Five Agrochemical Stocks Hedge Funds Like

    For years, there have been discussions regarding the future food needs, as the population is expected to reach 9 billion by 2050, which means that we will need to grow 50% more food to satisfy the demand. At the same time, expanding agricultural production has many downsides, since many countries employ agricultural practices from the […]

  • Benzinga4 days ago

    Argus Downgrades Monsanto After DOJ Blesses Bayer Merger

    The U.S. Department of Justice's move to approve German pharma company Bayer AG's acquisition of U.S.-based  Monsanto Company (NYSE: MON ) prompted at least one Wall Street analyst to turn bearish on the ...

  • Is It The Right Time To Buy Monsanto Company (NYSE:MON)?
    Simply Wall St.8 days ago

    Is It The Right Time To Buy Monsanto Company (NYSE:MON)?

    Let’s talk about the popular Monsanto Company (NYSE:MON). The company’s shares saw its share price hover around a small range of $116.6 to $125.2 over the last few weeks. ButRead More...

  • Reuters9 days ago

    Monsanto loses Indian legal battle over GM cotton patents

    A court ruled on Wednesday that Monsanto (MON.N) cannot claim patents on its genetically modified (GM) cotton seeds in India, the Indian company that brought the case said. Citing an Indian law that excludes seeds from being patented, Nuziveedu Seeds Ltd (NSL) argued that the U.S. seeds company was not eligible to claim patents and charge royalties from Indian seed companies.

  • Monsanto loses Indian legal battle over GM cotton patents
    Reuters9 days ago

    Monsanto loses Indian legal battle over GM cotton patents

    A court ruled on Wednesday that Monsanto (MON.N) cannot claim patents on its genetically modified (GM) cotton seeds in India, the Indian company that brought the case said. Citing an Indian law that excludes seeds from being patented, Nuziveedu Seeds Ltd (NSL) argued that the U.S. seeds company was not eligible to claim patents and charge royalties from Indian seed companies.

  • Monsanto Can't Have Patent on Bt Cotton in India, Court Says
    Bloomberg9 days ago

    Monsanto Can't Have Patent on Bt Cotton in India, Court Says

    Monsanto Co., the world’s largest seed company, can’t own a patent over genetically modified cotton seeds in India, a court ruled on Wednesday.

  • Bayer to sell digital farming business to clear way for Monsanto deal
    Reuters9 days ago

    Bayer to sell digital farming business to clear way for Monsanto deal

    Germany's Bayer plans to sell its digital farming business to BASF as part of changes to concessions it has offered to win over antitrust regulators for its proposed takeover of Monsanto. Bayer, which had previously only agreed to grant a licence to competitors, said on Wednesday that as part of the changes agreed with the European Commission it would retain a licence to certain digital farming applications. Digital farming, which combines sensors, software and precision machines, is still in its infancy but all the large players in the seeds and pesticides industry are developing digital offerings.

  • Reuters9 days ago

    Bayer to sell digital farming business to win approval for Monsanto deal

    Bayer said it was planning to sell its digital farming business, and not just grant a licence to competitors, to win antitrust approval for the planned takeover of Monsanto. In addition, certain Bayer seed treatment products will be offered for sale instead of Monsanto's NemaStrike seed treatment brand. "These changes have been made in response to corresponding indications from regulators," Germany's Bayer said in a statement on Wednesday.

  • FDA Restricts Sale of Bayer's Essure Birth Control Device
    Zacks10 days ago

    FDA Restricts Sale of Bayer's Essure Birth Control Device

    FDA puts restriction on the sale of Bayer's (BAYRY) implanted birth control device Essure.

  • Bloomberg10 days ago

    Bayer Is Nearing U.S. Antitrust Approval for Monsanto

    Bayer AG is close to winning U.S. antitrust approval to buy Monsanto Co., according to a person familiar with the matter, a move that would lift the last major hurdle to completing a $66 billion deal that ...

  • The Wall Street Journal10 days ago

    Stocks to Watch: Facebook, Amazon, Apple, Exxon Mobil, Boeing, Nvidia, Netflix, VeriFone, Monsanto

    Among the companies with shares expected to trade actively in Tuesday's session are Facebook, Amazon.com, Apple, Exxon Mobil, Boeing and Nvidia.

  • Bayer-Monsanto Merger Approval Came after Divestments
    Market Realist10 days ago

    Bayer-Monsanto Merger Approval Came after Divestments

    In Bayer-Monsanto Deal Receives European Union Approval, we discussed some of the concerns that delayed the approval of the Bayer-Monsanto (MON) merger by antitrust officials in various jurisdictions (XLB). Large overlaps in the business have been a concern for antitrust regulators. Bayer and Monsanto are complementary businesses with minimal overlap.

  • Why Monsanto Stock Popped Yesterday
    Market Realist10 days ago

    Why Monsanto Stock Popped Yesterday

    Monsanto (MON) stock surged on April 9, 2018, following news that the U.S. Department of Justice approved the merger with Bayer. The deal is one of the largest mergers in the agribusiness sector (MOO).

  • How RPM’s Specialty Segment Performed in 3Q18
    Market Realist10 days ago

    How RPM’s Specialty Segment Performed in 3Q18

    RPM International’s (RPM) Specialty segment comprises the smallest share of RPM’s overall revenue. This segment had a revenue share of 15.4% in fiscal 3Q18, compared with 15.6% in fiscal 3Q17. The segment’s revenue rose 6.5% YoY (year-over-year) to $170.1 million in fiscal 3Q18 from $159.7 million in fiscal 3Q17.

  • Stocks futures surge after China promises to cut auto tariffs, easing trade war fears
    Yahoo Finance10 days ago

    Stocks futures surge after China promises to cut auto tariffs, easing trade war fears

    Yahoo Finance's LIVE market coverage and analysis of what you need to watch in the stock market begins each day at 9:25 a.m. ET.

  • Reuters10 days ago

    Bayer shares jump on report of U.S. antitrust deal on Monsanto

    Bayer (BAYGn.DE) shares jumped nearly 5 percent on Tuesday following a media report that the U.S. Justice Department will allow the German drugs and pesticides group to acquire Monsanto (MON.N) in a $62.5 billion (44.14 billion pounds) deal. The Justice Department reached an agreement in principle with Bayer and Monsanto in recent days after the companies agreed to sell more assets, the Wall Street Journal said late on Monday, citing people familiar with the matter. Under the deal, Bayer agreed to sell additional seed and treatment assets to BASF (BASFn.DE) and agreed to make concessions related to digital agriculture, it said.

  • Expect Stocks to Rise on Continued Bullishness
    InvestorPlace10 days ago

    Expect Stocks to Rise on Continued Bullishness

    Despite worsening U.S.-China trade tensions on Friday (when President Trump unveiled another $100 billion worth of tariffs) and over-the-weekend headlines out of Syria (alleged chemical weapons attack and an airstrike by Israel), the bulls blasted stocks higher out of the gate. The catalyst for the selloff was word of a raid on Trump’s personal attorney on the order of Special Counsel Robert Mueller. Trump could well fire Mueller or members of the Justice Department in what looks like a political ploy to get Trump top testify under oath.

  • Monsanto Company (MON) Surges: Stock Moves 6.2% Higher
    Zacks10 days ago

    Monsanto Company (MON) Surges: Stock Moves 6.2% Higher

    Monsanto (MON) was a big mover last session, as the company saw its shares rise more than 6% on the day amid huge volumes.

  • Bayer's Lucky General Wins Recruits for $66 Billion Monsanto Deal
    Bloomberg10 days ago

    Bayer's Lucky General Wins Recruits for $66 Billion Monsanto Deal

    Bayer's long-running takeover of Monsanto is starting to look more attractive.